Effects of cholecystokinin (CCK)-8 on hypothalamic oxytocin-secreting neurons in rats lacking CCK-A receptor

Auton Neurosci. 2005 Aug 31;121(1-2):16-25. doi: 10.1016/j.autneu.2005.05.002.

Abstract

Peripheral administration of cholecystokinin (CCK)-8 selectively activates oxytocin (OXT)-secreting neurons in the supraoptic (SON) and the paraventricular nuclei (PVN) with the elevation of plasma OXT level in rats. We examined the effects of intravenous (iv) administration of CCK-8 on the neuronal activity of hypothalamic OXT-secreting neurons and plasma OXT level in Otsuka Long-Evans Tokushima Fatty (OLETF) rats that have a congenital defect in the expression of the CCK-A receptor gene. In situ hybridization histochemistry (ISH) for c-fos mRNA revealed that the expression of the c-fos gene was not induced in the SON, the PVN, the nucleus of the tractus solitarius (NTS) and the area postrema (AP) 30 min after iv administration of CCK-8 (20 and 40 microg/kg) in OLETF rats. In Long-Evans Tokushima Otsuka (LETO) rats (controls), c-fos mRNA was detected abundantly in those nuclei 30 min after iv administration of CCK-8 (20 microg/kg). Immunohistochemistry for c-fos protein (Fos) showed that the distributions of Fos-like immunoreactivity (LI) were identical to the results obtained from ISH. Dual immunostaining for OXT and Fos revealed that Fos-LI was mainly observed in OXT-secreting neurons in the SON and the PVN of LETO rats 90 min after iv administration of CCK-8 (20 microg/kg). Radioimmunoassay for OXT and arginine vasopressin (AVP) showed that iv administration of CCK-8 did not cause significant change in the plasma OXT and AVP levels in OLETF rats, while iv administration of CCK-8 caused a significant elevation of plasma OXT level without changing the plasma AVP level in LETO rats. These results suggest that peripheral administration of CCK-8 may selectively activate the hypothalamic OXT-secreting neurons and brainstem neurons through CCK-A receptor in rats.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Genetically Modified
  • Arginine Vasopressin / blood
  • C-Reactive Protein / drug effects
  • C-Reactive Protein / metabolism
  • Cholecystokinin / pharmacology*
  • Dose-Response Relationship, Drug
  • Gene Expression Regulation / drug effects*
  • Gene Expression Regulation / physiology
  • Hypothalamus / cytology
  • Hypothalamus / drug effects*
  • In Situ Hybridization / methods
  • Male
  • Nerve Tissue Proteins / drug effects
  • Nerve Tissue Proteins / metabolism
  • Oncogene Proteins v-fos / genetics
  • Oncogene Proteins v-fos / metabolism
  • Oxytocin / metabolism*
  • Peptide Fragments / pharmacology*
  • Radioimmunoassay / methods
  • Rats
  • Rats, Inbred OLETF
  • Receptor, Cholecystokinin A / deficiency*
  • Time Factors

Substances

  • Nerve Tissue Proteins
  • Oncogene Proteins v-fos
  • Peptide Fragments
  • Receptor, Cholecystokinin A
  • cholecystokinin 8
  • neuronal pentraxin
  • Arginine Vasopressin
  • Oxytocin
  • C-Reactive Protein
  • Cholecystokinin